Effect of Behavioral Sleep Intervention on Lower Urinary Tract Symptoms in Older Women
Shachi Tyagi
120 participants
Mar 5, 2023
INTERVENTIONAL
Conditions
Summary
Urgency urinary incontinence (UUI) is common in older people and vastly reduces quality of life, yet the cause and mechanism of disease are not well understood. This study will investigate the role of adding behavioral sleep intervention to the standard pharmacotherapy in treatment of UUI among older adults, and the brain mechanisms involved in continence by evaluating brain changes. This will expand the current knowledge of how the sleep affects bladder control, and better characterize the brain mechanisms in maintaining continence.
Eligibility
Inclusion Criteria4
- ambulatory women aged 60+ years
- urgency incontinence or urge-predominant mixed incontinence (able to differentiate between stress symptoms-cough, laugh, exercise-and leakage following the sudden onset of a strong urge to void that is difficult to defer during questioning on telephone screening) occurring at least five times weekly for ≥ 3 months despite treatment for reversible causes
- nocturia ≥2 each night
- subjects with current or previous use of anticholinergic medications will be considered for the study if willing to go through a washout period of at least 4 weeks of duration
Exclusion Criteria12
- contraindication to any of the drugs used (e.g., mirabegron, prophylactic antibiotics)
- cognitive impairment (MOCA score \<24 or inability to accurately complete a voiding diary, perform a 24-hour pad test, reliably take daily medication, or comply with fMRI testing)
- prior treatment with intradetrusor onabotulinum toxin or sacral neuromodulation.
- spinal cord injury; history of pelvic irradiation, advanced uterine or bladder cancer; multiple sclerosis
- urethral obstruction; urinary retention \[PVR \>200 ml\]
- interstitial cystitis; artificial sphincter implant
- medical instability or expected change in medication during the study
- conditions that preclude fMRI testing, such as history of claustrophobia, history or suspicion of implanted metal or electronic object
- requirement for intravenous antibiotics for bacterial endocarditis prophylaxis or presence of multiple allergies to the antibiotics available in our protocol
- chronic or recurrent bowel issues, e.g. IBS, colitis, fecal incontinence
- known allergy to study medication or interaction with current medications
- severe uncontrolled hypertension \>180 mmHg systolic or \>100 mmHg diastolic
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Medication to treat overactive bladder
A behavioral intervention for insomnia
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05604222